Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 1;12(3):682-692.
doi: 10.1093/advances/nmaa125.

Coronavirus Disease 2019 (COVID-19) and Nutritional Status: The Missing Link?

Affiliations
Review

Coronavirus Disease 2019 (COVID-19) and Nutritional Status: The Missing Link?

Renata Silverio et al. Adv Nutr. .

Abstract

Coronavirus disease 2019 (COVID-19) is an emerging disease that has reached pandemic status by rapidly spreading worldwide. Elderly individuals and patients with comorbidities such as obesity, diabetes, and hypertension show a higher risk of hospitalization, severe disease, and mortality by acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. These patients frequently show exacerbated secretion of proinflammatory cytokines associated with an overreaction of the immune system, the so-called cytokine storm. Host nutritional status plays a pivotal role in the outcome of a variety of different infectious diseases. It is known that the immune system is highly affected by malnutrition, leading to decreased immune responses with consequent augmented risk of infection and disease severity. Body composition, especially low lean mass and high adiposity, has consistently been linked to worsened prognosis in many different diseases. In this review, evidence concerning the impact of nutritional status on viral infection outcomes is discussed.

Keywords: BMI; COVID-19; SARS-CoV-2; immune system; obesity; sarcopenia; undernutrition.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Obesity and related comorbidities are associated with physiological alterations leading to higher susceptibility to infection and pathogenicity and transmission of COVID-19. ACE2, angiotensin-converting enzyme 2; COVID-19, coronavirus disease 2019; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

References

    1. World Health Organization . Coronavirus disease (COVID-19). Situation report—120[Internet]. [cited May 19, 2020]. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/2....
    1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. JAMA[Internet]. 2020;323:1239. [cited Apr 23, 2020]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32091533. - PubMed
    1. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Yet al. . Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet[Internet]. 2020[cited Aug 4, 2020];395:507–13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32007143. - PMC - PubMed
    1. Zhu J, Ji P, Pang J, Zhong Z, Li H, He C, Zhang J, Zhao C. Clinical characteristics of 3062 COVID‐19 patients: a meta‐analysis. J Med Virol[Internet]. 2020;jmv.25884. [cited Aug 4, 2020]. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.25884. - DOI - PMC - PubMed
    1. Yang W, Cao Q, Qin L, Wang X, Cheng Z, Pan A, Dai J, Sun Q, Zhao F, Qu Jet al. . Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city, Zhejiang, China. J Infect[Internet]. 2020;80:388–93. [cited Aug 4, 2020]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32112884. - PMC - PubMed

Publication types